Tailored-Biomaterials Based Potential Strategies for Cardiovascular Disease
| dc.authorid | 0009-0002-1371-6836 | |
| dc.authorid | 0000-0001-8682-4278 | |
| dc.authorid | 0000-0002-0586-134X | |
| dc.contributor.author | Bhullar, Sukhwinder K. | |
| dc.contributor.author | Mondal, Haimanti | |
| dc.contributor.author | Thomas, John | |
| dc.contributor.author | Ruzgar, Duygu Gazioglu | |
| dc.contributor.author | Chandrasekaran, Natarajan | |
| dc.contributor.author | Mukherjee, Amitava | |
| dc.contributor.author | Willerth, Stephanie M. | |
| dc.date.accessioned | 2026-02-08T15:15:53Z | |
| dc.date.available | 2026-02-08T15:15:53Z | |
| dc.date.issued | 2024 | |
| dc.department | Bursa Teknik Üniversitesi | |
| dc.description.abstract | Cardiovascular disease is a significant health concern worldwide, and varied effective treatment and prevention methods have been developed. Among these, tailored biomaterials-based strategies such as stents, scaffolds, patches, and drug delivery systems have emerged as a promising avenue. These devices are designed to match the mechanical and biological mechanisms of the cardiovascular system, ensuring optimal performance and compatibility. By effectively treating or preventing cardiovascular diseases, these devices have the potential to improve patient health outcomes significantly. They can restore blood flow by addressing blocked arteries and regenerate damaged cardiac tissue by delivering bioactive agents or cells directly to the affected area in a targeted, sustained, and controllable manner. Therefore, the objective of this article is to summarize the available evidence on these tailored biomaterial-based tunable cardiovascular devices. This knowledge can help to transform cardiovascular medicine for the treatment or prevention of cardiovascular disease and restore cardiac function to improve patients' quality of life. | |
| dc.identifier.doi | 10.24976/Discov.Med.202436187.142 | |
| dc.identifier.endpage | 1554 | |
| dc.identifier.issn | 1539-6509 | |
| dc.identifier.issn | 1944-7930 | |
| dc.identifier.issue | 187 | |
| dc.identifier.pmid | 39190371 | |
| dc.identifier.startpage | 1544 | |
| dc.identifier.uri | https://doi.org/10.24976/Discov.Med.202436187.142 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.12885/6011 | |
| dc.identifier.volume | 36 | |
| dc.identifier.wos | WOS:001296062500001 | |
| dc.identifier.wosquality | Q3 | |
| dc.indekslendigikaynak | Web of Science | |
| dc.indekslendigikaynak | PubMed | |
| dc.language.iso | en | |
| dc.publisher | Discovery Medicine | |
| dc.relation.ispartof | Discovery Medicine | |
| dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | |
| dc.rights | info:eu-repo/semantics/openAccess | |
| dc.snmz | WOS_KA_20260207 | |
| dc.subject | biomaterials | |
| dc.subject | biomaterial-based cardiovascular devices | |
| dc.subject | tailored auxetic effects | |
| dc.subject | tuned deformation mechanisms | |
| dc.subject | controlled drug delivery | |
| dc.title | Tailored-Biomaterials Based Potential Strategies for Cardiovascular Disease | |
| dc.type | Review Article |












